Optimer Pharmaceuticals, Inc. (OPTR)

[surf1944]

January 9, 2012
08:47 EDT OPTR
theflyonthewall.com: Optimer provides update on DIFICID tablets launch
Optimer Pharmaceuticals provided an update on commercial sales of DIFICID, or fidaxomicin, tablets since launching the antibacterial drug in July 2011 for the treatment of Clostridium difficile associated-diarrhea, or CDAD, in adults 18 years of age or older in the U.S. Pedro Lichtinger, President and CEO commented: "Sales of DIFICID in the U.S. over the past five and a half months reflect the strong initial demand for a new antibacterial drug providing a superior sustained clinical response through 25 days after the end of treatment for CDAD. Wholesale level shipments in Q4 of 2011 increased almost 87% compared to Q3, drawing down wholesaler inventory levels. We also observed continued strong month over month growth through the fourth quarter of about 11%." :theflyonthewall.com